Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
File(s)
Accepted version
Author(s)
Type
Journal Article
Abstract
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
Date Issued
2015-10-23
Date Acceptance
2015-10-01
Citation
Nature Reviews Cancer, 2015, 15, pp.668-679
ISSN
1474-175X
Publisher
Nature Publishing Group
Start Page
668
End Page
679
Journal / Book Title
Nature Reviews Cancer
Volume
15
Copyright Statement
© 2015 Macmillan Publishers Limited. All rights reserved
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363691100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
BRCA MUTATION CARRIERS
TUBAL-INTRAEPITHELIAL-CARCINOMA
OLAPARIB MAINTENANCE THERAPY
SINGLE-THRESHOLD RULE
HUMAN BREAST-TUMORS
CELL LUNG-CANCER
FALLOPIAN-TUBE
T-CELLS
GERMLINE MUTATIONS
SOMATIC MUTATIONS
Cystadenocarcinoma, Serous
Female
Humans
Neoplasm Grading
Ovarian Neoplasms
Prognosis
Survival Rate
Oncology & Carcinogenesis
11 Medical And Health Sciences
Publication Status
Published